[{"id":"3b6ac439-85dd-4ce9-8f0d-f7d06cac5169","acronym":"","url":"https://clinicaltrials.gov/study/NCT05839106","created_at":"2023-05-03T15:04:23.524Z","updated_at":"2025-02-25T16:27:19.857Z","phase":"Phase 1/2","brief_title":"Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05839106","lead_sponsor":"Biotheus Inc.","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PM1032"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 07/08/2022","start_date":" 07/08/2022","primary_txt":" Primary completion: 04/10/2025","primary_completion_date":" 04/10/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-05-05"}]